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Abstract 
We previously identified D-dopachrome tautomerase (DDT) as a novel adipokine whose mRNA 
levels in adipocytes are negatively correlated with obesity-related clinical parameters, and 
which acts on adipocytes to regulate lipid metabolism.  Here we investigated functions of DDT 
on preadipocytes.  Recombinant DDT (rDDT) enhanced both the expression and secretion of 
interleukin-6 (IL-6) in SGBS cells, a human preadipocyte cell line.  Treatment with rDDT 
increased levels of phosphorylated ERK1/2, but not p38, in SGBS cells, and rDDT-induced 
IL-6 mRNA expression was attenuated by pretreatment with an ERK inhibitor, U0126.  
Knockdown of CD74, but not CD44, inhibited rDDT-induced IL-6 mRNA expression in SGBS 
cells.  These results suggested that the rDDT-induced IL-6 expression in preadipocytes 
occurred through the CD74-ERK pathway.  Furthermore, in SGBS cells subjected to 
adipogenic induction, rDDT decreased the amount of triacylglycerol, number of cells with oil 
droplets, and levels of mRNA encoding adipocyte marker proteins.  Increased expression of 
CCAAT/enhancer binding protein families and peroxisome proliferation activated receptor γ2 
during adipogenesis was inhibited in the cells treated with rDDT.  These results suggested 
DDT to inhibit adipogenesis by suppressing the expression of genes encoding adipogenic 
regulators in preadipocytes. 
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1. Introduction 
   Adipose tissue (AT) is not only an energy storage organ, but also a source of various 
secreted functional factors, adipokines.  Adipokines include proinflammatory factors such as 
resistin, tumor necrosis factor-α, interleukin-6 (IL-6), monocyte chemoattractant protein-1, and 
plasminogen activator inhibitor-1 and anti-inflammatory factors such as adiponectin and leptin 
[1].  AT is composed of mature adipocytes and a stromal vascular fraction (SVF) that includes 
preadipocytes, macrophages, and vascular cells.  Obese AT is characterized by an increased 
AT mass and facilitates the infiltration of macrophages [2].  These macrophages interact with 
adipocytes or preadipocytes to induce secretion of inflammatory cytokines and free fatty acids 
[3], resulting in systemic insulin resistance which is a risk factor for type 2 diabetes, 
hypertension, and dyslipidemia [4]. 
   D-dopachrome tautomerase (DDT) was identified as an enzyme converting D-dopachrome 
into 5,6-dihydroxyindole [5], but its physiological significance has not been elucidated due to an 
inactive substrate in mammals.  DDT shares homology with macrophage migration inhibitory 
factor (MIF) in primary (33% identical) and tertiary structure [6].  MIF acts as a cytokine 
involved in the amplification of inflammatory and immune responses [7, 8].  Furthermore, 
MIF converts D-dopachrome into another tautomer, 5,6-dihydroxyindole-2-carboxylic acid [9].  
Thus, the similarities with MIF suggest DDT to act as a cytokine with a certain function.  
Recently, DDT was reported to be detectable in human serum and to function as a MIF homolog 
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in non-small cell lung carcinomas and macrophages through CD74, a component of the MIF 
receptor complex [10, 11, 12]. 
   Previously, we found DDT to be secreted from adipocytes by using a proteomic approach 
[13].  Levels of DDT mRNA in adipocytes were negatively associated with body mass index 
or fat areas and the expression of DDT was observed in mature adipocytes, but not in 
preadipocytes [13].  DDT acts on adipocytes in an autocrine/paracrine manner to regulate lipid 
metabolism through inhibition of protein kinase A (PKA) activity and/or activation of 
AMP-activated protein kinase (AMPK), and administration of a recombinant form of the protein 
in db/db mice improved glucose intolerance and serum levels of free fatty acids, suggesting that 
DDT acts as an adipokine with anti-obesity [13].  To clarify further the function of DDT in AT, 
we here investigated the actions of DDT on preadipocytes.  
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2. Materials and methods 
2.1. Purification of recombinant human DDT (rDDT) and MIF (rMIF) 
   rDDT was obtained as described previously [13].  Human MIF cDNA was amplified 
by reverse transcription PCR (RT-PCR) using total RNA from THP-1 cells, a human monocyte 
cell line, and the recombinant protein was produced in the same manner.  The concentration of 
endotoxin in these recombinant proteins was calculated to be below 1 EU/µg by using the 
ToxinSensor Endotoxin Detection System (Genscript, Piscataway, NJ).  Tautomerase activity 
of rMIF was assessed using the L-dopachrome methyl ester as a substrate, measuring the 
changes in absorbance at 475 nm [9, 14].  Briefly, 720 µl of 10 mM sodium phosphate/1 mM 
EDTA, pH 6.0 was added to a 1 ml disposable cuvette, and then 48 µl of 10 mM L-dopa methyl 
ester (Sigma, St. Louis, MO) and 32 µl of sodium m-periodate (Sigma) were added to generate 
L-dopachrome methyl ester.  The spontaneous decay of absorbance at 475 nm was monitored 
for 30 sec.  Each 5 µg of rMIF and equal volume of PBS as a control was added to the cuvette 
and the accelerated decay of absorbance at 475 nm due to dopachrome tautomerization was 
monitored for 15 min.   
 
2.2. Cell culture 
   SGBS cells, a human preadipocyte cell line with a high capacity for adipose 
differentiation [16], were kindly provided by Dr. Wabitsch.  The cells were cultured on 6-well 
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plates in Dulbecco’s Modified Eagle’s Medium (DMEM)/Ham’s F12 (1:1) (WAKO, Tokyo, 
Japan) supplemented with 10% fetal bovine serum (FBS) (GIBCO, Grand Island, NY), 33 µM 
biotin (Sigma), and 17 µM panthothenic acid (Sigma).  DDT knockdown adipocytes were 
made by infection with an adenovirus expressing short hairpin RNA (shRNA) for the DDT gene 
as described previously [13].  After confluent SGBS cells were pre-incubated with serum-free 
DMEM/Ham’s F12 (1:1) for 12 h, they were treated with rDDT or rMIF at 20 nM or the 
indicated concentrations for 12 h.  To investigate the signal transduction pathway for DDT, 
SGBS cells were pretreated with 10 µM U0126 (Calbiochem, San Diego, CA) or dimethyl 
sulfoxide (DMSO; WAKO) for 30 min and then treated with 20 nM rDDT for 12 h. 
 
2.3. RNA extraction and real-time RT-PCR 
   Total RNA from the cells was extracted with ISOGEN (Nippongene, Tokyo, Japan).  
Each cDNA was synthesized from total RNA using the Prime scriptTM RT Reagent Kit (TaKaRa, 
Shiga, Japan).  Real-time RT-PCR was performed on an Applied Biosystems Prism 7300 Real 
Time PCR system (Applied Biosystems, Foster City, CA) using THUNDERBIRDTMSYBR® 
qPCR Mix (TOYOBO, Tokyo, Japan) with each specific primer set (Table 1).  The expression 
of each gene was normalized to that of glyceraldehyde-3-phosphate dehydrogenase.  The data 
were analyzed using 7300 System Sequence Detection software (version 3.1; Applied 
Biosystems). 
 8 
 
2.4. Western blotting 
   Each cell was washed with phosphate-buffered saline (PBS) and lysed in a mixture of 
sodium dodecyl sulfate (SDS) sample buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 
0.004% bromophenol blue, 125 mM Tris, pH 7.6) and lysis buffer (150 mM NaCl, 1 mM EDTA, 
1% Triton-X, 50 mM Tris, pH 7.6) at a volume ratio of 1:4.  The lysate was boiled at 95°C for 
3 min, and centrifuged at 16,100 x g for 30 min.  The supernatant was subjected to 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted to polyvinylidene difluoride 
membranes (Immobilon Transfer Membranes; Millipore, Bedford, MA).  After incubation in 
blocking solution (Blocking One; Nakalai tesque, Kyoto, Japan), the membranes were incubated 
with a 1:1,000-diluted rabbit antibody against ERK1/2, phospho-ERK1/2, p38, or phospho-p38 
(Cell signaling, Beverly, CA), or a 1:2,000-diluted mouse antibody against β-actin (Sigma).  
The membranes were incubated with an anti-rabbit or -mouse IgG-horseradish 
peroxidase-conjugated secondary antibody (1:40,000 or 1:80,000, respectively; GE Healthcare, 
Buckinghamshire, UK).  Signal detection was performed using Immobilon Western Detection 
Reagent (Millipore) and exposure to X-ray film. 
 
2.5. Enzyme-linked immunosorbent assay (ELISA) 
   SGBS cells were incubated with serum-free DMEM/Ham’s F12 (1:1) with or without 20 
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nM rDDT for 24 h, and the cells and conditioned medium were collected.  The conditioned 
medium and cell lysate in the lysis buffer were centrifuged at 16,100 x g for 20 min to remove 
debris.  The concentration of IL-6 was measured by Quantikine Human IL-6 Immunoassay 
(R&D systems, Minneapolis, MN) according to the manufacturer's directions. 
 
2.6. Transfection of small interfering RNA (siRNA) 
   SGBS cells were transfected with 1 µM CD74 siRNA (Invitrogen, Carlsbad, CA), 100 
nM CD44 siRNA (Invitrogen), or negative control siRNA (Silencer® Negative Control #1 
siRNA; Applied Biosystems) by electroporation using a Microporator MP-100 (Digital Bio, 
Seoul, South Korea). The CD74- and CD44-specific siRNA sequences were 
5’-AUCCAUGACUGGCUUCUGAUCUUCC-3’ and 5’-UAUUGAAAGCCUUGCAGAGGU- 
CAGC-3’, respectively.  Forty-eight hours after the transfection, the culture medium was 
changed to serum-free DMEM/Ham’s F12 (1:1) containing 20 nM rDDT for 12 h. 
 
2.7. Evaluation of adipogenesis 
   SGBS cells were preincubated with rDDT for 12 h and subjected to adipogenic 
induction as described by Wabitsch et al. [16] in the presence or absence of rDDT.  Briefly, 
confluent SGBS cells were cultured in FBS-free differentiation medium: DMEM/Ham’s F12 
(1:1) supplemented with 33 µM biotin, 17 µM pantothenic acid, 500 µM 
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3-isobutyl-1-methylxanthine (IBMX; Sigma), 2 µM troglitazone (Sigma), 20 nM insulin 
(WAKO), 100 nM cortisol (WAKO), 0.2 nM triiodothyronine (WAKO), 25 nM dexamethasone 
(WAKO), and 10 µg/ml human transferrin (Calbiochem, Los Angels, CA).  After 4 days, this 
medium was replaced with differentiation medium excluding IBMX, troglitazone, and 
dexamethasone, which was changed every 3 days.  At 9 days after the induction, the cells were 
fixed with formaldehyde for 20 min.  After being washed with 60% isopropanol, the cells were 
stained with Oil red O (Muto Pure Chemicals, Tokyo, Japan).  The cells were washed with 
60% isopropanol followed by distilled water, and observed under a microscope.  After the cells 
were dried, Oil red O was eluted with 1 ml/well of isopropanol and the absorbance was 
measured at 500 nm by a spectrophotometer (Ultrospec 6300 pro; GE Healthcare).  For the 
counting of cells with lipid droplets, fixed cells were also treated with 0.2% Triton-X100 for 15 
min, washed with PBS, and subjected to 4’,6’-diamidine-2-phenylindole dihydrochloride 
(DAPI) and Sudan III staining.  The cells were observed under a fluorescence microscope 
(TE-2000; Nikon, Tokyo, Japan).  The ratio of Sudan III-positive cells to DAPI-stained cells in 
6 randomly selected low-power fields (x 100) was calculated.  
  
2.8. Statistical analysis 
   Statistical analyses were performed using Student’s t-test. Differences were considered to be 
significant when the P-value was less than 0.05. 
 11 
3. Results 
3.1. rDDT promotes IL-6 expression and secretion in preadipocytes 
   We previously reported that the expression of genes encoding enzymes related to lipid 
metabolism was increased in DDT knockdown adipocytes differentiated from SGBS cells [13].  
Further analysis revealed a reduction of IL-6 mRNA levels in the cells (Fig. 1A).  Because 
DDT knockdown adipocytes included undifferentiated preadipocytes and IL-6 was reported to 
be mainly secreted from preadipocytes rather than mature adipocytes [17, 18], we hypothesized 
that DDT acts on preadipocytes to induce IL-6 gene expression.  To demonstrate this, we 
examined the effect of rDDT on IL-6 expression in SGBS preadipocytes.  As expected, 
treatment with rDDT dose-dependently induced IL-6 gene expression in SGBS cells (Fig. 1B) 
and increased IL-6 protein levels both in the cells and in the conditioned medium (Fig. 1C).  
These results indicated that DDT acts on preadipocytes to promote IL-6 expression and 
secretion.  To compare the effect of DDT with that of MIF, which is similar to DDT in tertiary 
structure, on SGBS cells, we prepared rMIF and confirmed its enzymatic activity (Fig. 1D).  
Treatment with rMIF did not influence IL-6 mRNA levels in SGBS cells (Fig. 1E).  To 
confirm the biological activity of rMIF, effect of rMIF on mRNA expression of matrix 
metalloproteinase (MMP)-1 and MMP-3, which are induced by MIF in synovial fibroblasts [19], 
was investigated.  rMIF up-regulated MMP-1 and MMP-3 gene expression in SGBS cells (Fig. 
1F), suggesting that the recombinant retained the biological activity.  In addition, MMP-1 and 
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MMP-3 gene expression in SGBS cells was also induced by rDDT (Fig. 1G).  These results 
suggest that DDT partially, but not completely, acts as MIF’s homolog in SGBS cells.       
 
3.2. ERK signaling is involved in rDDT-induced IL-6 expression 
   We examined the involvement of MAPK signaling in rDDT-induced IL-6 expression in 
preadipocytes.  Levels of phosphorylated ERK1/2, but not p38, were increased in SGBS cells 
after 30 min of rDDT treatment (Fig. 2A).  In addition, IL-6 gene expression induced by rDDT 
was completely inhibited in the presence of U0126, an ERK inhibitor (Fig. 2B).  These results 
indicated that DDT promotes IL-6 expression in SGBS cells through the ERK/MAPK pathway. 
 
3.3. CD74, but not CD44, is involved in rDDT-induced IL-6 expression 
   Because the tertiary structure of DDT is similar to that of MIF [6], whose signal is mediated 
by a CD74/CD44 receptor complex [20, 21], we examined the involvement of these components 
in rDDT-induced IL-6 expression using SGBS cells transduced with siRNA against the CD74 or 
CD44 gene.  CD74 and CD44 gene expression was confirmed to be inhibited in these cells 
(Fig. 3A, B).  rDDT-induced IL-6 gene expression was attenuated in CD74 knockdown SGBS 
cells (Fig. 3C).  Conversely, the knockdown of CD44 had no effect (Fig. 3D).  These results 
suggested that CD74, but not CD44, is involved in the signaling for DDT-induced IL-6 
expression in preadipocytes. 
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3.4. rDDT inhibits adipogenesis in preadipocytes 
   Next, we investigated the effects of rDDT on adipogenesis in preadipocytes.  The 
amount of triacylglycerol in SGBS cells subjected to adipogenesis in the presence of rDDT was 
less than that in control cells (Fig. 4A) and rDDT dose-dependently decreased the number of 
cells with lipid droplets (Fig. 4B).  Furthermore, mRNA levels of genes expressed in 
adipocytes, such as peroxisome proliferator-activated receptor (PPAR) γ2, CCAAT/enhancer 
binding protein (C/EBP) α, aP2, and adiponectin, were significantly lower in the cells treated 
with rDDT (Fig. 4C).  These results clearly indicated that rDDT inhibited adipogenesis in 
SGBS cells. 
 
3.5. rDDT inhibits induction of adipogenic regulators during adipogenesis   
   To reveal the molecular mechanism involved in the inhibition of adipogenesis by rDDT, 
mRNA levels of adipogenic regulators during adipogenesis were examined in rDDT-treated 
SGBS cells.  The expression of C/EBPβ and C/EBPδ, involved in the early stages of 
adipogenesis, was inhibited in rDDT-treated cells (Fig. 5).  Furthermore, mRNA levels of 
adipogenic regulators in the late stages, C/EBPα and PPARγ2, whose expression is induced by 
C/EBPδ and C/EBPβ, were lower at 6 days after adipogenic induction in rDDT-treated cells 
(Fig. 5).  These results suggested that DDT impairs adipogenesis by inhibiting the induction of 
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adipogenic regulators during adipogenesis. 
 
4. Discussion 
   DDT is secreted from adipocytes and acts in a paracrine or autocrine manner to regulate 
lipid metabolism in adipocytes [13].  In the present study, we demonstrated that DDT also acts 
on preadipocytes to promote the expression of IL-6 and to inhibit adipogenesis.  DDT is 
similar to MIF in tertiary structure [6], and both proteins exhibit tautomerase activity using 
D-dopachrome as a substrate [5, 9].  Recently, DDT was reported to be a functional homolog 
of MIF because it binds to CD74, a component of the MIF receptor complex, leading to the 
activation of ERK and its downstream proinflammatory pathways [11, 12].  Indeed, MIF and 
DDT had the same effects on MMP-1 or MMP-3 mRNA expression in SGBS cells in the 
present study.  However, DDT, but not MIF, increased IL-6 expression in SGBS cells.  
Furthermore, expression of DDT was observed in adipocytes, but not in preadipocytes, and 
increased during adipogenesis [13], whereas MIF is expressed in both cell types and its mRNA 
levels do not increase with differentiation [22].  These results suggest that the function of DDT 
in AT is not completely the same as that of MIF.  MIF activates the MAPK cascade (the ERK 
pathway) through a CD74/CD44 receptor complex and is involved in cell proliferation, 
differentiation, survival, and inflammatory responses in various cell types [20, 21, 23].  It is 
considered that CD74 and CD44 are involved in MIF binding and intracellular signal 
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transduction, respectively [20].  In the present study, knockdown of CD74, but not CD44, 
attenuated rDDT-induced IL-6 gene expression in preadipocytes, suggesting that the DDT 
receptor complex may consist of CD74 and component(s) other than CD44 in preadipocytes.  
Alternatively, there is a possibility that CD74 solely mediates DDT to stimulate IL-6 expression 
in preadipocytes.  The difference in the actions of DDT and MIF on preadipocytes may be 
derived from different components of the receptor complex.  Further experiments are 
necessary to identify the DDT receptor or the complex in preadipocytes. 
   IL-6 is a pleiotropic inflammatory cytokine involved in immune and inflammatory 
responses and associated with hematopoiesis and carcinogenesis [24].  On the other hand, 
transient IL-6 up-regulation is reported to contribute improvement of insulin sensitivity [25].  
For example, enhancement of insulin signaling in liver by adiponectin is mediated by IL-6 
secretion from AT macrophages [26] and IL-6 released from skeletal muscle during exercise 
enhances insulin secretion from pancreatic islets directly or indirectly through glucagon-like 
peptide-1 [27, 28].  We previously showed that the administration of rDDT in db/db mice 
improved their glucose intolerance [13].  Therefore, we hypothesized that rDDT-induced IL-6 
in preadipocytes is involved in improvement of glucose intolerance in db/db mice treated with 
rDDT, however, we have not demonstrated the hypothesis yet.  Further experiments need to 
clarify the significance of rDDT-induced IL-6 secretion from preadipocytes in glucose 
tolerance. 
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   DDT was revealed to have an inhibitory effect on adipogenesis.  Although IL-6 secreted 
from obese AT is reported to inhibit adipogenesis [29], adipogenesis inhibited by rDDT may 
mainly depend on mechanisms other than induction of IL-6 in preadipocytes.  IL-6 is reported 
to inhibit the expression of C/EBPα, but not C/EBPβ, C/EBPδ, and PPARγ, during adipogenesis 
in 3T3-L1 [29]; however, the gene expression of these four adipogenic regulators was inhibited 
in rDDT-treated SGBS cells.  For example, phosphorylation of ERK induced by Pref1, a factor 
inhibiting adipogenesis, is reported to up-regulate the expression of Sox-9, which directly binds 
to the promoter region of C/EBPβ and C/EBPδ to suppress their transcription [30].  As well as 
Pref1, DDT may inhibit adipogenesis by activating the ERK/MAPK pathway in preadipocytes.  
However, we could not exclude the involvement of other factors in the inhibition of 
adipogenesis by DDT. 
In conclusion, DDT secreted from adipocytes acts on preadipocytes to promote IL-6 
expression and to inhibit adipogenesis by suppressing the induction of genes encoding 
adipogenic regulators. 
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Figure Legends 
Fig. 1.  rDDT induces IL-6 expression in SGBS cells.  (A) IL-6 mRNA levels in adipocytes 
differentiated from SGBS cells expressing shNC and shDDT were measured by real-time 
RT-PCR.  The levels are shown relative to those in cells expressing shNC.  (B) IL-6 mRNA 
levels were measured in SGBS cells treated with each concentration of rDDT.  The levels are 
shown relative to those in untreated cells.  (C) IL-6 protein levels in the cell lysate (a left 
graph) and conditioned medium (a right graph) from untreated cells (rDDT(-)) or rDDT-treated 
cells (rDDT(+)) were measured by ELISA.  IL-6 protein levels in the lysate were normalized 
to total cellular protein levels and are shown relative to those in the untreated cell lysate.  (D) 
Enzymatic activity of rMIF was measured by decrease in absorbance at 475 nm of 
L-dopachrome methyl ester.  The data are shown relative to absorbance of controls.  Data are 
the mean ± S.E. (n=3).  (E) IL-6 mRNA levels in SGBS cells treated with rMIF at the 
indicated concentration were measured by real-time RT-PCR.  The levels are shown relative to 
those in untreated cells.  (F, G) MMP-1 and MMP-3 mRNA levels in SGBS cells treated with 
rMIF (F) or rDDT (G) were measured by real-time RT-PCR.  The levels are shown relative to 
those in untreated cells.  Each graph is representative of at least 3 independent experiments.  
Data are the mean ± S.E. (n=3).  *P<0.05. 
 
Fig. 2.  rDDT-induced IL-6 expression in preadipocytes is mediated by ERK activation.  (A) 
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Phosphorylation of ERK1/2 and p38 in rDDT-treated SGBS cells at the indicated time points 
was assessed by Western blotting.  β-actin was used as internal control.  (B) IL-6 mRNA 
levels in SGBS cells treated with or without rDDT in the presence of U0126 or DMSO were 
measured by real-time RT-PCR.  The levels in rDDT-treated cells (black bars) are shown 
relative to those in untreated cells (white bars).  Each graph is representative of at least 3 
independent experiments.  Data are the mean ± S.E. (n=3).  *P<0.05. 
 
Fig. 3.  rDDT-induced IL-6 expression in preadipocytes is mediated by CD74.  (A, B) mRNA 
levels of CD74 (A) and CD44 (B) in SGBS cells transfected with siRNA against CD74 
(siCD74) and CD44 (siCD44) were measured by real-time RT-PCR, respectively.  The levels 
are shown relative to those in cells transfected with nontargeting siRNA (siNC).  (C, D) IL-6 
mRNA levels in rDDT-treated SGBS cells transfected with siCD74 (C) or siCD44 (D) were 
measured by real-time RT-PCR.  The levels in rDDT-treated cells (black bars) are shown 
relative to those in untreated cells (white bars).  Each graph is representative of at least 3 
independent experiments.  Data are the mean ± S.E. (n=3).  *P<0.05. 
 
Fig. 4.  rDDT inhibits adipogenesis in SGBS cells.  Confluent SGBS cells were pre-incubated 
with serum-free medium supplemented with or without rDDT (20 nM or the indicated 
concentration), and then induced to differentiate into adipocytes in the presence or absence of 
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rDDT.  At 9 days after the adipogenic induction, the degree of differentiation into adipocytes 
was evaluated by Oil red O staining (A), Sudan III staining (B), and mRNA levels of adipogenic 
markers (C).  (A) The cells stained by Oil red O were observed under a microscope at 400 x 
magnification (left images), and absorbance of eluted Oil red O was measured (right graph).  
(B) The cells were double-stained by DAPI and Sudan III and observed under a microscope at 
400 x magnification (left images).  The right graph represents the average percentage of Sudan 
III- positive cells among DAPI-stained cells per microscopic low-power field (x 100).  (C) 
mRNA levels of adipocyte-specific genes, PPARγ2, C/EBPα, adiponectin, and aP2, were 
measured by real-time RT-PCR.  The levels in rDDT-treated cells (rDDT(+)) are shown 
relative to those in untreated cells (rDDT(-)).  Each graph is representative of at least 3 
independent experiments.  Data are the mean ± S.E. (n=3).  *P<0.05. 
 
Fig. 5.  rDDT inhibits induction of adipogenic regulators during adipogenesis.  The 
experiment was performed in the same manner as Fig. 3.  At 0, 2, 4, and 6 day(s) after the 
adipogenic induction, mRNA levels of C/EBPβ, C/EBPδ, C/EBPα, and PPARγ2 in the cells 
treated with rDDT (dashed lines) and in control cells (solid lines) were measured by real-time 
RT-PCR.  The levels are shown relative to those in untreated cells at day 0.  Each graph is 
representative of at least 3 independent experiments.  Data are the mean ± S.E. (n=3).  
*P<0.05. 
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Table 1 
Sequences of primers used for real-time RT-PCR 
Gene Forward (5’-3’) Reverse (5’-3’) 
adiponectin  GTGATGGCAGAGATGGCAC ACACTGAATGCTGAGCGGTA 
aP2 CCTGGTACATGTGCAGAAAT AGAGTTCAATGCGAACTTCA 
CD44 GGCGCAGATCGATTTGAATA TTCTCCATCTGGGCCATTGT 
CD74 TAGACAGATCCCCGTTCCTG TGGAAAACATTGGCTCTTCC 
C/EBPα AAGAAGTCGGTGGACAAGAACAG  GCAGGCGGTCATTGTCACT 
C/EBPβ CTGGAGACGCAGCACAAG ACAGCTGCTCCACCTTCTTC 
C/EBPδ GGTGCCCGCTGCAGTTT CTCGCAGTTTAGTGGTGGTAAGTC 
GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC 
IL-6 TACCCCCAGGAGAAGATTCC TTTTCTGCCAGTGCCTCTTT 
MMP-1 ATGCTGAAACCCTGAAGGTG CTGCTTGACCCTCAGAGACC 
MMP-3 GCAGTTTGCTCAGCCTATCC GAGTGTCGGAGTCCAGCTTC 
PPARγ2 AGCAAACCCCTATTCCATGCT ATCAGTGAAGGAATCGCTTTCTG 
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